182 related articles for article (PubMed ID: 9255581)
1. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.
Weston A; Godbold JH
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):919-26. PubMed ID: 9255581
[TBL] [Abstract][Full Text] [Related]
2. p53 haplotype determination in breast cancer.
Weston A; Pan CF; Ksieski HB; Wallenstein S; Berkowitz GS; Tartter PI; Bleiweiss IJ; Brower ST; Senie RT; Wolff MS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):105-12. PubMed ID: 9037561
[TBL] [Abstract][Full Text] [Related]
3. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.
Weston A; Caporaso NE; Perrin LS; Sugimura H; Tamai S; Krontiris TG; Trump BF; Hoover RN; Harris CC
Environ Health Perspect; 1992 Nov; 98():61-7. PubMed ID: 1486864
[TBL] [Abstract][Full Text] [Related]
4. Allelic frequency of a p53 polymorphism in human lung cancer.
Weston A; Perrin LS; Forrester K; Hoover RN; Trump BF; Harris CC; Caporaso NE
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):481-3. PubMed ID: 1302561
[TBL] [Abstract][Full Text] [Related]
5. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
[TBL] [Abstract][Full Text] [Related]
6. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.
Pierce LM; Sivaraman L; Chang W; Lum A; Donlon T; Seifried A; Wilkens LR; Lau AF; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1199-204. PubMed ID: 11097227
[TBL] [Abstract][Full Text] [Related]
7. Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients.
Bonafé M; Ceccarelli C; Farabegoli F; Santini D; Taffurelli M; Barbi C; Marzi E; Trapassi C; Storci G; Olivieri F; Franceschi C
Clin Cancer Res; 2003 Oct; 9(13):4860-4. PubMed ID: 14581358
[TBL] [Abstract][Full Text] [Related]
8. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
Wang YC; Chen CY; Chen SK; Chang YY; Lin P
Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
[TBL] [Abstract][Full Text] [Related]
9. P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients.
Kara N; Karakus N; Ulusoy AN; Ozaslan C; Gungor B; Bagci H
DNA Cell Biol; 2010 Jul; 29(7):387-92. PubMed ID: 20380571
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
[TBL] [Abstract][Full Text] [Related]
11. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer.
Weston A; Ling-Cawley HM; Caporaso NE; Bowman ED; Hoover RN; Trump BF; Harris CC
Carcinogenesis; 1994 Apr; 15(4):583-7. PubMed ID: 7908608
[TBL] [Abstract][Full Text] [Related]
12. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype.
Jin X; Wu X; Roth JA; Amos CI; King TM; Branch C; Honn SE; Spitz MR
Carcinogenesis; 1995 Sep; 16(9):2205-8. PubMed ID: 7554076
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.
Kato S; Shields PG; Caporaso NE; Hoover RN; Trump BF; Sugimura H; Weston A; Harris CC
Cancer Res; 1992 Dec; 52(23):6712-5. PubMed ID: 1423319
[TBL] [Abstract][Full Text] [Related]
14. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
Buller RE; Sood A; Fullenkamp C; Sorosky J; Powills K; Anderson B
Cancer Gene Ther; 1997; 4(4):239-45. PubMed ID: 9253509
[TBL] [Abstract][Full Text] [Related]
15. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
[TBL] [Abstract][Full Text] [Related]
16. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
Liu G; Miller DP; Zhou W; Thurston SW; Fan R; Xu LL; Lynch TJ; Wain JC; Su L; Christiani DC
Cancer Res; 2001 Dec; 61(24):8718-22. PubMed ID: 11751390
[TBL] [Abstract][Full Text] [Related]
17. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
18. Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-ras gene: comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas.
Kotsinas A; Gorgoulis VG; Zacharatos P; Mariatos G; Kokotas S; Liloglou T; Ikonomopoulos J; Zoumpourlis V; Kyroudi A; Field JK; Asimacopoulos PJ; Kittas C
Cancer Genet Cytogenet; 2001 Apr; 126(2):147-54. PubMed ID: 11376808
[TBL] [Abstract][Full Text] [Related]
19. P53 codon 72 polymorphism in Taiwanese breast cancer patients.
Chen FM; Ou-Yang F; Yang SF; Tsai EM; Hou MF
Kaohsiung J Med Sci; 2013 May; 29(5):259-64. PubMed ID: 23639512
[TBL] [Abstract][Full Text] [Related]
20. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
